Actively Recruiting
Sleeve-pex: A Randomized Trial to Reduce Reflux After Sleeve Gastrectomy
Led by Helse Forde · Updated on 2024-10-30
550
Participants Needed
4
Research Sites
377 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The goal of this clinical trial is to test gastropexy as a measure to reduce reflux in morbidly obese patients being submitted to sleeve gastrectomy. The main questions it aims to answer are: Does gastropexy reduce reflux symptoms? Does gastropexy reduce objective evidence of reflux? Participants will be randomized to gastropexy or no gastropexy, and researchers will compare these groups to see if reflux (symptoms / objective evidence of) is different in the two groups.
CONDITIONS
Official Title
Sleeve-pex: A Randomized Trial to Reduce Reflux After Sleeve Gastrectomy
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients planned for bariatric surgery with primary laparoscopic sleeve gastrectomy (LSG)
You will not qualify if you...
- Age below 18 years
- Use of acid-reducing medication for reasons other than reflux
- Previous antireflux surgery
- Inability to understand and respond to patient-reported outcome questionnaires
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 4 locations
1
Helse Forde
Førde, Norway
Not Yet Recruiting
2
Aleris Oslo
Oslo, Norway
Actively Recruiting
3
Volda sjukehus
Volda, Norway
Actively Recruiting
4
Voss sjukehus
Voss, Norway
Actively Recruiting
Research Team
V
Villy Vage, MD PhD
CONTACT
J
John Andersen, PhD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
DOUBLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
PREVENTION
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here